Rhythm Pharmaceuticals, Inc. (RYTM)

Last Closing Price: 116.80 (2026-11-19)

Beginning Cash (Quarterly)

Beginning Cash: The amount of cash reported by the company on its previous statement.

Rhythm Pharmaceuticals, Inc. (RYTM) had Beginning Cash of $54.82M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$92.13M
$-42.35M
$12.17M
$79.96M
$131.40M
$-39.27M
$-1.49M
$-40.76M
$-40.76M
$-41.37M
$-41.37M
$-41.37M
$-41.37M
$-39.27M
$-39.02M
69.05M
69.05M
$-0.61
$-0.61
Balance Sheet Financials
$419.36M
$0.57M
$23.77M
$443.13M
$150.89M
--
$90.70M
$241.59M
$87.97M
$184.87M
$201.54M
69.31M
Cash Flow Statement Financials
$-56.40M
$54.96M
$-12.81M
Beginning Cash
$54.82M
$41.26M
$-13.56M
$74.18M
--
$-1.46M
Fundamental Metrics & Ratios
2.78
--
--
--
--
86.79%
-42.63%
-42.63%
--
-44.24%
-45.97%
$-56.90M
--
--
--
0.21
0.39
2.35
38.22
-47.03%
-22.38%
-9.34%
-20.53%
$2.91
$-0.82
$-0.82